1. Home
  2. TRT vs RANI Comparison

TRT vs RANI Comparison

Compare TRT & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRT
  • RANI
  • Stock Information
  • Founded
  • TRT 1958
  • RANI 2012
  • Country
  • TRT United States
  • RANI United States
  • Employees
  • TRT N/A
  • RANI N/A
  • Industry
  • TRT Industrial Machinery/Components
  • RANI Medicinal Chemicals and Botanical Products
  • Sector
  • TRT Technology
  • RANI Health Care
  • Exchange
  • TRT Nasdaq
  • RANI Nasdaq
  • Market Cap
  • TRT 22.7M
  • RANI 23.2M
  • IPO Year
  • TRT N/A
  • RANI 2021
  • Fundamental
  • Price
  • TRT $5.30
  • RANI $0.50
  • Analyst Decision
  • TRT
  • RANI Strong Buy
  • Analyst Count
  • TRT 0
  • RANI 4
  • Target Price
  • TRT N/A
  • RANI $7.75
  • AVG Volume (30 Days)
  • TRT 2.8K
  • RANI 429.7K
  • Earning Date
  • TRT 11-11-2025
  • RANI 11-13-2025
  • Dividend Yield
  • TRT N/A
  • RANI N/A
  • EPS Growth
  • TRT N/A
  • RANI N/A
  • EPS
  • TRT 0.00
  • RANI N/A
  • Revenue
  • TRT $35,548,000.00
  • RANI $1,200,000.00
  • Revenue This Year
  • TRT N/A
  • RANI N/A
  • Revenue Next Year
  • TRT N/A
  • RANI N/A
  • P/E Ratio
  • TRT $1,203.05
  • RANI N/A
  • Revenue Growth
  • TRT N/A
  • RANI N/A
  • 52 Week Low
  • TRT $4.62
  • RANI $0.39
  • 52 Week High
  • TRT $7.88
  • RANI $3.75
  • Technical
  • Relative Strength Index (RSI)
  • TRT 51.33
  • RANI 46.37
  • Support Level
  • TRT N/A
  • RANI $0.47
  • Resistance Level
  • TRT $5.50
  • RANI $0.51
  • Average True Range (ATR)
  • TRT 0.08
  • RANI 0.04
  • MACD
  • TRT -0.20
  • RANI -0.00
  • Stochastic Oscillator
  • TRT 96.36
  • RANI 34.71

About TRT Trio-Tech International

Trio-Tech International is a provider of third-party semiconductor testing and burn-in services through its laboratories in Southeast Asia. The company operates in four segments namely Manufacturing, Testing services, Distribution, and Real Estate. Its Manufacturing segment manufactures both front-end and back-end semiconductor test equipment and related peripherals. The Testing Services segment renders services to the manufacturer and purchaser of semiconductors and other entities. Its Distribution segment is involved in the distribution of its products. The company's Real Estate segment consists of investment in real estate. Its geographical area of operations includes the United States, Singapore, Malaysia, Thailand, and China. It derives maximum revenue from Testing services Segment.

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

Share on Social Networks: